- Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors
Hiroshi Kobayashi et al, 2022, Journal of Obstetrics and Gynaecology Research CrossRef - Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients
InĂªs Soares Marques et al, 2023, International Journal of Molecular Sciences CrossRef - Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia
Hiroshi Kobayashi et al, 2023, Biomedicines CrossRef - Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence
Yolanda Prado et al, 2023, Advances in Molecular Pathology CrossRef - Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
Ryo Tamura et al, 2022, Cancers CrossRef - Clear cell carcinoma of the ovary and venous thromboembolism: a systematic review and meta-analysis
Hamidreza Didar et al, 2023, Current Medical Research and Opinion CrossRef - The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system
Hiroshi Kobayashi et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef